166 related articles for article (PubMed ID: 23116197)
1. Proteomics-based analysis of invasion-related proteins in malignant gliomas.
Maruo T; Ichikawa T; Kanzaki H; Inoue S; Kurozumi K; Onishi M; Yoshida K; Kambara H; Ouchida M; Shimizu K; Tamaru S; Chiocca EA; Date I
Neuropathology; 2013 Jun; 33(3):264-75. PubMed ID: 23116197
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma.
Onishi M; Ichikawa T; Kurozumi K; Inoue S; Maruo T; Otani Y; Fujii K; Ishida J; Shimazu Y; Yoshida K; Michiue H; Antonio Chiocca E; Date I
Brain Tumor Pathol; 2015 Jul; 32(3):184-94. PubMed ID: 25697644
[TBL] [Abstract][Full Text] [Related]
3. Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.
Inoue S; Ichikawa T; Kurozumi K; Maruo T; Onishi M; Yoshida K; Fujii K; Kambara H; Chiocca EA; Date I
World Neurosurg; 2012 Dec; 78(6):670-82. PubMed ID: 22120277
[TBL] [Abstract][Full Text] [Related]
4. Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models.
Onishi M; Ichikawa T; Kurozumi K; Fujii K; Yoshida K; Inoue S; Michiue H; Chiocca EA; Kaur B; Date I
Neuropathology; 2013 Apr; 33(2):162-74. PubMed ID: 22989076
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
6. Annexin A2 promotes glioma cell invasion and tumor progression.
Zhai H; Acharya S; Gravanis I; Mehmood S; Seidman RJ; Shroyer KR; Hajjar KA; Tsirka SE
J Neurosci; 2011 Oct; 31(40):14346-60. PubMed ID: 21976520
[TBL] [Abstract][Full Text] [Related]
7. Identification of gliotropic factors that induce human stem cell migration to malignant tumor.
An JH; Lee SY; Jeon JY; Cho KG; Kim SU; Lee MA
J Proteome Res; 2009 Jun; 8(6):2873-81. PubMed ID: 19351187
[TBL] [Abstract][Full Text] [Related]
8. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
9. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
10. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a canine glioma cell line as related to established experimental brain tumor models.
Rainov NG; Koch S; Sena-Esteves M; Berens ME
J Neuropathol Exp Neurol; 2000 Jul; 59(7):607-13. PubMed ID: 10901232
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
[TBL] [Abstract][Full Text] [Related]
13. Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
Chen YH; Hueng DY; Tsai WC
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373180
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of annexin 2 decreases migration of human glioma cells in vitro.
Tatenhorst L; Rescher U; Gerke V; Paulus W
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645
[TBL] [Abstract][Full Text] [Related]
15. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
[TBL] [Abstract][Full Text] [Related]
16. Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies.
Beckner ME; Chen X; An J; Day BW; Pollack IF
Lab Invest; 2005 Mar; 85(3):316-27. PubMed ID: 15654357
[TBL] [Abstract][Full Text] [Related]
17. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.
Chidambaram A; Fillmore HL; Van Meter TE; Dumur CI; Broaddus WC
J Neurosurg; 2012 Apr; 116(4):843-53. PubMed ID: 22313360
[TBL] [Abstract][Full Text] [Related]
18. RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.
Jin H; Zhang X; Su J; Teng Y; Ren H; Yang L
Mol Med Rep; 2015 Nov; 12(5):6617-25. PubMed ID: 26328748
[TBL] [Abstract][Full Text] [Related]
19. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
[TBL] [Abstract][Full Text] [Related]
20. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
